Q1 2026 · 13F-HR
SABBY MANAGEMENT, LLCholdings as filed
Filed 2026-05-15 · accession 0001104659-26-061764
The Brief · SABBY MANAGEMENT, LLC · Q1 2026
AI · grounded in 13F
SABBY MANAGEMENT, LLC closed its position in ISHARES TR, reducing its exposure by $13.88M. The fund also exited positions in BIG TREE CLOUD HLDGS LTD DSY, EMPERY DIGITAL INC EMPD, and BLINK CHARGING CO BLNK. On the buy side, the fund established new positions in ALPHATON CAPITAL CORP ALP for $654,785 and BRIACELL THERAPEUTICS CORP BCTXL for $392,145. Additionally, the fund increased its holdings in the SPDR S&P 500 ETF SPY.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F953 | SPY | SPDR S&P 500 ETF | $29.1M | 64.5% | 447 | PUT | SHARED |
| 464287955 | — | ISHARES TR | $7.4M | 16.5% | 300 | PUT | SHARED |
| 78462F103 | SPY | SPDR S&P 500 ETF | $1.8M | 3.94% | 2,734 | Common | SHARED |
| 374396956 | GEVO | GEVO INC | $1.4M | 3.18% | 5,252 | PUT | SHARED |
| 00370M903 | ABVX | ABIVAX SA | $857,395 | 1.90% | 77 | CALL | SHARED |
| G7185A136 | ALP | ALPHATON CAPITAL CORP | $654,785 | 1.45% | 2,072,103 | Common | SHARED |
| 107930125 | BCTXL | BRIACELL THERAPEUTICS CORP | $392,145 | 0.87% | 380,686 | Common | SHARED |
| 81720R604 | SNES | SENESTECH INC | $358,394 | 0.80% | 218,533 | Common | SHARED |
| G1263B132 | DSY | BIG TREE CLOUD HLDGS LTD | $337,147 | 0.75% | 137,611 | Common | SHARED |
| 488445956 | ZVRA | ZEVRA THERAPEUTICS INC | $316,880 | 0.70% | 340 | PUT | SHARED |
| 107930307 | BCTX | BRIACELL THERAPEUTICS CORP | $309,704 | 0.69% | 73,915 | Common | SHARED |
| 826165951 | SIDU | SIDUS SPACE INC | $243,368 | 0.54% | 1,049 | PUT | SHARED |
| 89856T401 | TC | TOKEN CAT LTD | $241,686 | 0.54% | 23,239 | Common | SHARED |
| G71700119 | CPOP | POP CULTURE GROUP CO LTD | $201,129 | 0.45% | 664,449 | Common | SHARED |
| 60855D408 | MBRX | MOLECULIN BIOTECH INC | $171,798 | 0.38% | 75,021 | Common | SHARED |
| 59564R880 | — | BIODEXA PHARMACEUTICALS PLC | $159,092 | 0.35% | 257,472 | Common | SHARED |
| 039014303 | RKDA | ARCADIA BIOSCIENCES INC | $158,085 | 0.35% | 114,554 | Common | SHARED |
| 87283P109 | TRX | TRX GOLD CORP | $150,000 | 0.33% | 100,000 | Common | SHARED |
| 457637700 | INM | INMED PHARMACEUTICALS INC | $142,046 | 0.32% | 220,260 | Common | SHARED |
| 13471N409 | CANF | CAN FITE BIOFARMA LTD | $131,933 | 0.29% | 42,559 | Common | SHARED |
| G2161P165 | SXTC | CHINA SXT PHARMACEUTICALS INC | $131,326 | 0.29% | 78,170 | Common | SHARED |
| 76135L804 | REVB | REVELATION BIOSCIENCES INC | $119,318 | 0.26% | 99,432 | Common | SHARED |
| 320703408 | CLDI | CALIDI BIOTHERAPEUTICS INC | $103,855 | 0.23% | 434,903 | Common | SHARED |
| 095633608 | BJDX | BLUEJAY DIAGNOSTICS INC | $52,856 | 0.12% | 28,726 | Common | SHARED |
| 55234L204 | LYRA | LYRA THERAPEUTICS INC | $51,103 | 0.11% | 104,059 | Common | SHARED |
| 87978U207 | TPST | TEMPEST THERAPEUTICS INC | $29,284 | 0.06% | 17,856 | Common | SHARED |
| 107930117 | BCTXZ | BRIACELL THERAPEUTICS CORP | $28,945 | 0.06% | 206,753 | Common | SHARED |
| 03815U607 | BNBX | BNB PLUS CORP | $8,666 | 0.02% | 13,541 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.